Effects of a Microbiome-Targeted Diet on Cardiometabolic Risk in People Living with HIV: A Randomized Controlled Trial with Mediation Analysis

Background Cardiovascular disease (CVD) is a leading cause of morbidity among people living with HIV (PLWH), partly driven by gut microbiome dysbiosis. Whether microbiome-targeted dietary interventions can reduce CVD risk in this population remains unclear. We aimed to evaluate the effectiveness of a microbiome-targeted dietary intervention on CVD risk and gut microbiome in PLWH and to examine potential microbial mediation. Methods We conducted a 12-week, single-blind, parallel-group randomized controlled trial in PLWH with elevated CVD risk in China. Participants were assigned to a microbiome-targeted diet (n=29), consisting of a culturally adapted, polyphenol-rich dietary pattern supplemented with Spirulina, or a control group receiving standard dietary advice (n=31). The primary outcome was 10-year CVD risk estimated via pooled cohort equations (PCE). Secondary outcomes included cardiometabolic biomarkers and gut microbiota profiles assessed by 16S rRNA sequencing. Exploratory mediation analyses were conducted to evaluate indirect associations involving microbial taxa. Results In the primary analysis, the intervention was associated with reductions in PCE-estimated ASCVD risk (P=0.024), systolic blood pressure (P<0.001), and self-reported CVD symptoms (P=0.001). It also increased α-diversity and induced compositional shifts, with decreased Klebsiella, Enterobacteriaceae, and Escherichia-Shigella, and increased Prevotella stercorea, Faecalibacterium, and Sutterella wadsworthensis. Exploratory mediation analyses identified significant indirect effects involving Prevotella stercorea (βindirect[95% CI]=-1.905 [-4.618, -0.064]) for SBP and Methanobrevibacter smithii (-1.804 [-4.428, -0.024]) for DBP. Conclusions A culturally tailored, microbiome-targeted dietary intervention showed potential cardiometabolic benefits among PLWH. Exploratory indirect-effect analyses suggested possible microbiome-related pathways, which require confirmation in longitudinal and mechanistic studies. Microbiome-informed dietary strategies may be promising, non-pharmacologic approaches for CVD prevention in HIV care.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-11-21
DOI
https://doi.org/10.1093/ofid/ofag703
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of a Microbiome-Targeted Diet on Cardiometabolic Risk in People Living with HIV: A Randomized Controlled Trial with Mediation Analysis

Junwen Yu, Bei Wu, Zheng Zhu, Hongzhou Lu et al.
Open Forum Infectious Diseases
Gut microbiota and health
article

Effects of a Microbiome-Targeted Diet on Cardiometabolic Risk in People Living with HIV: A Randomized Controlled Trial with Mediation Analysis

Junwen Yu, Bei Wu, Zheng Zhu, Hongzhou Lu, Xiaoning Liu, Xiang Qi, Changrong Yuan
article en

Abstract

Background Cardiovascular disease (CVD) is a leading cause of morbidity among people living with HIV (PLWH), partly driven by gut microbiome dysbiosis. Whether microbiome-targeted dietary interventions can reduce CVD risk in this population remains unclear. We aimed to evaluate the effectiveness of a microbiome-targeted dietary intervention on CVD risk and gut microbiome in PLWH and to examine potential microbial mediation. Methods We conducted a 12-week, single-blind, parallel-group randomized controlled trial in PLWH with elevated CVD risk in China. Participants were assigned to a microbiome-targeted diet (n=29), consisting of a culturally adapted, polyphenol-rich dietary pattern supplemented with Spirulina, or a control group receiving standard dietary advice (n=31). The primary outcome was 10-year CVD risk estimated via pooled cohort equations (PCE). Secondary outcomes included cardiometabolic biomarkers and gut microbiota profiles assessed by 16S rRNA sequencing. Exploratory mediation analyses were conducted to evaluate indirect associations involving microbial taxa. Results In the primary analysis, the intervention was associated with reductions in PCE-estimated ASCVD risk (P=0.024), systolic blood pressure (P<0.001), and self-reported CVD symptoms (P=0.001). It also increased α-diversity and induced compositional shifts, with decreased Klebsiella, Enterobacteriaceae, and Escherichia-Shigella, and increased Prevotella stercorea, Faecalibacterium, and Sutterella wadsworthensis. Exploratory mediation analyses identified significant indirect effects involving Prevotella stercorea (βindirect[95% CI]=-1.905 [-4.618, -0.064]) for SBP and Methanobrevibacter smithii (-1.804 [-4.428, -0.024]) for DBP. Conclusions A culturally tailored, microbiome-targeted dietary intervention showed potential cardiometabolic benefits among PLWH. Exploratory indirect-effect analyses suggested possible microbiome-related pathways, which require confirmation in longitudinal and mechanistic studies. Microbiome-informed dietary strategies may be promising, non-pharmacologic approaches for CVD prevention in HIV care.

Open Forum Infectious Diseases
Fudan University (CN), New York University Shanghai (CN), Shenzhen Third People’s Hospital (CN), New York University (US)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon